Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Cytokinetics receives FDA orphan drug status for Ck-2127107 to treat SMA

pharmaceutical-technologyMay 18, 2017

Tag: FDA , Orphan Drug , sma

PharmaSources Customer Service